Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$35.77M-19.1%-$30.51M+16.0%-$32.59M+5.7%-$36.36M-13.7%-$30.02M-20.0%
$270K-10.6%$320K+5.3%$288K+6.7%$310K+14.0%$302K+15.7%
$6.9M+5.2%$6.28M+20.7%$5.63M+11.4%$6.57M+31.6%$6.55M+32.2%
-$32.44M+0.3%-$22.48M+19.9%-$25.11M+12.8%-$30.84M-20.4%-$32.53M-7.8%
$2K-99.5%$227K+3.7%$35K-91.6%$63K-81.1%$387K+77.5%
-$17.98M-180%-$110.54M-$76.93M$22.45M+136%
$61.14M+555,718%$1.5M+161%$109.45M+86,766%$134.3M+16,359%$11K-100.0%
$10.73M+207%-$4M-126%-$26.2M$26.53M-$10.07M-131%
-$32.44M+1.5%-$22.71M+19.7%-$25.15M+13.9%-$30.91M-19.1%-$32.92M-8.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Oric Pharmaceuticals, Inc. generate?
Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
What is Oric Pharmaceuticals, Inc.'s free cash flow?
After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.